According to Hikma Pharmaceuticals 's latest financial reports the company's total assets are โฌ4.48 Billion. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | โฌ4.23 B | 1.57% |
2022-12-31 | โฌ4.16 B | 7.97% |
2021-12-31 | โฌ3.86 B | 14.83% |
2020-12-31 | โฌ3.36 B | -4.17% |
2019-12-31 | โฌ3.50 B | 14.77% |
2018-12-31 | โฌ3.05 B | 8.26% |
2017-12-31 | โฌ2.82 B | -31.93% |
2016-12-31 | โฌ4.14 B | 74.64% |
2015-12-31 | โฌ2.37 B | 28.33% |
2014-12-31 | โฌ1.85 B | 32.5% |
2013-12-31 | โฌ1.39 B | 6.8% |
2012-12-31 | โฌ1.30 B | 7.79% |
2011-12-31 | โฌ1.21 B | 46.74% |
2010-12-31 | โฌ0.82 B | 15.83% |
2009-12-31 | โฌ0.71 B | 3.26% |
2008-12-31 | โฌ0.69 B | 12.9% |
2007-12-31 | โฌ0.61 B | 65.44% |
2006-12-31 | โฌ0.37 B | 10.17% |
2005-12-31 | โฌ0.33 B | 84.89% |
2004-12-31 | โฌ0.18 B | 94.09% |
2003-12-31 | โฌ93.61 M | 3.16% |
2002-12-31 | โฌ90.74 M |